NKX2-1 and neoplasm: Presently, there are no other suitable Cre drivers that specifically targets Nkx2-1-lineage cells and would be instrumental to further address in vivo the potential role of Nkx2-1 gene dosage in sporadic tumor development in thyroid and lung.